April 20, 2018
Article
A new class of injectable monoclonal antibodies directed against calcitonin gene related peptide (CGRP) or its receptor may offer hope to migraineurs who have not found effective prophylactic therapy.
April 18, 2018
Slideshow
Newly approved medications for various types of pain, generalized myasthenia gravis, and Parkinson disease will be fodder for discussion at AAN 2018. Here’s a brief overview of the therapies the FDA has approved within the past 6 months.
February 13, 2015
Slideshow
The FDA has recently approved a number of drugs for a variety of neurologic disorders, including Parkinson's disease and MS. Here are 8 of the newest.
December 02, 2014
Article
A new study bolsters evidence that bilingualism contributes to cognitive reserve, postpones symptoms of dementia, and delays diagnosis of Alzheimer disease.